Lake Street Capital Begins Coverage on LENSAR (NASDAQ:LNSR)

Lake Street Capital started coverage on shares of LENSAR (NASDAQ:LNSR – Free Report) in a research note released on Tuesday morning, Benzinga reports. The brokerage issued a buy rating and a $8.00 target price on the stock. LENSAR Trading Down 9.4 % Shares of LNSR stock opened at $3.65 on Tuesday. The company’s 50-day moving […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Weighs in on Acurx Pharmaceuticals, Inc.’s FY2028 Earnings (NASDAQ:ACXP)
Next post Jazz Pharmaceuticals (NASDAQ:JAZZ) Rating Reiterated by Truist Financial